OSA patients show increased numbers of CD4+ and CD8+ T cells, with CD8+ T cells exhibiting an activated phenotype, especially subsets expressing natural killer receptors CD56 and CD16, which exhibit stronger cytotoxicity (62–64). The gene discussed is CD4; the disease is obstructive sleep apnea syndrome.